Magnetically Tunable Chondrocyte Cell Sheet Engineering for Osteoarthritis Thera...
Magnetically Tunable Chondrocyte Cell Sheet Engineering for Osteoarthritis Therapy
Osteoarthritis (OA) is a disease that gradually degrades the cartilage joints, affecting more than 50 million people in Europe. With no known treatment, this population is at risk of lower quality of life and permanent disability....
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
RTI2018-099389-A-I00
CRIOGELES ACTIVADOS POR GENES PARA REPARACION DE CARTILAGO
109K€
Cerrado
SAF2012-40149-C02-01
ESTUDIO PRECLINICO PARA EVALUAR CELULAS MESENQUIMALES HUMANA...
70K€
Cerrado
ANCHOR
Articular cartilage regeneration through the recruitment of...
150K€
Cerrado
PID2019-110709RB-I00
DESARROLLO DE MICROCAPSULAS BIOADHESIVAS PARA NUEVOS TRATAMI...
254K€
Cerrado
SAF2011-22576
BIONGENIERIA DEL PULMON MEDIANTE CULTIVO DE CELULAS MADRE EN...
127K€
Cerrado
BFU2008-02010
FUNCION DE OSTERIX Y P38 EN OSTEOGENESIS INDUCIDA POR BMPS
169K€
Cerrado
Información proyecto MACROS
Duración del proyecto: 36 meses
Fecha Inicio: 2022-08-10
Fecha Fin: 2025-08-31
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Osteoarthritis (OA) is a disease that gradually degrades the cartilage joints, affecting more than 50 million people in Europe. With no known treatment, this population is at risk of lower quality of life and permanent disability. The chondrocyte is a native cell in the cartilage joints that has been studied as a promising cell therapy agent for early-stage OA. Recently, by using a stimuli-responsive (SR) culture plate, many cell types can be prepared as a sheet-like cluster (cell sheet) analogous to the native biological tissue, entailing the enhanced regenerative efficacy when used as cell therapy. However, it is challenging to prepare the chondrocyte cell sheet, as the chondrocyte gradually loses the cartilage feature upon being cultured on the stiff SR plate. In this project, I aim to prepare the cartilage-like chondrocyte cell sheet by developing an innovative technique that is premised on the tuning of substrate stiffness during the cell culture stage. I will focus on three objectives: (1) to develop a new cell sheet-fabrication substrate that has the magnetically tunable stiffness, (2) to study the proof-of-concept of the tunable stiffness technique for modifying the model cell sheet activities, and (3) to apply this dynamic technique to obtain the cartilage-like chondrocyte cell sheet of which its regenerative efficacy against early-stage OA will be evaluated. To perform this project, I will draw from and extend upon my current expertise and works in biomaterial development and stiffness-cell interaction, with that of academic host Prof. Berensmeier (magnetic nanotechnology) and of industrial partner Dr. Vonk (cartilage cell therapy). This synergized academic-industry partnership will continue to the non-academic placement, wherein I will undertake the next-stage preclinical developments of chondrocyte cell sheets in a deeper and more relevant context of OA treatment. The proposed project gives a great contribution to the OA-stricken European society.